Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
BMC Psychiatry ; 23(1): 336, 2023 05 12.
Article in English | MEDLINE | ID: mdl-37173664

ABSTRACT

BACKGROUND: Studies using self-reports indicate that individuals with ADHD are at increased risk for functional impairments in social and occupational settings, but evidence around real-life instability remains limited. It is furthermore unclear if these functional impairments in ADHD differ across sex and across the adult lifespan. METHOD: A longitudinal observational cohort design of 3,448,440 individuals was used to study the associations between ADHD and residential moves, relational instability and job shifting using data from Swedish national registers. Data were stratified on sex and age (18-29 years, 30-39 years, and 40-52 years at start of follow up). RESULTS: 31,081 individuals (17,088 males; 13,993 females) in the total cohort had an ADHD-diagnosis. Individuals with ADHD had an increased incidence rate ratio (IRR) of residential moves (IRR 2.35 [95% CI, 2.32-2.37]), relational instability (IRR = 1.07 [95% CI, 1.06-1.08]) and job shifting (IRR = 1.03 [95% CI, 1.02-1.04]). These associations tended to increase with increasing age. The strongest associations were found in the oldest group (40-52 years at start of follow). Women with ADHD in all three age groups had a higher rate of relational instability compared to men with ADHD. CONCLUSION: Both men and women with a diagnosis of ADHD present with an increased risk of real-life instability in different domains and this behavioral pattern was not limited to young adulthood but also existed well into older adulthood. It is therefore important to have a lifespan perspective on ADHD for individuals, relatives, and the health care sector.


Subject(s)
Attention Deficit Disorder with Hyperactivity , Adult , Male , Humans , Female , Aged , Young Adult , Adolescent , Attention Deficit Disorder with Hyperactivity/epidemiology , Attention Deficit Disorder with Hyperactivity/diagnosis , Incidence , Sweden/epidemiology
2.
J Hosp Infect ; 101(1): 30-37, 2019 Jan.
Article in English | MEDLINE | ID: mdl-29909095

ABSTRACT

AIM: To describe a hospital outbreak of influenza B virus (InfB) infection during season 2015/2016 by combining clinical and epidemiological data with molecular methods. METHODS: Twenty patients diagnosed with InfB from a hospital outbreak over a four-week-period were included. Nasopharyngeal samples (NPS) positive for InfB by multiplex real-time polymerase chain reaction were sent for lineage typing and whole genome sequencing (WGS). Medical records were reviewed retrospectively for data regarding patient characteristics, localization, exposure and outcome, and assembled into a timeline. In order to find possible connections to the hospital outbreak, all patients with a positive NPS for influenza from the region over an extended time period were also reviewed. FINDINGS: All 20 cases of InfB were of subtype B/Yamagata, and 17 of 20 patients could be linked to each other by either shared room or shared ward. WGS was successful or partially successful for 15 of the 17 viral isolates, and corroborated the epidemiological link supporting a close relationship. In the main affected ward, 19 of 75 inpatients were infected with InfB during the outbreak period, resulting in an attack rate of 25%. One probable case of influenza-related death was identified. CONCLUSION: InfB may spread within an acute care hospital, and advanced molecular methods may facilitate assessment of the source and extent of the outbreak. A multi-faceted approach, including rapid diagnosis, early recognition of outbreak situations, simple rules for patient management and the use of regular infection control measures, may prevent nosocomial transmission of influenza virus.


Subject(s)
Cross Infection/classification , Cross Infection/epidemiology , Disease Outbreaks , Influenza B virus/classification , Influenza B virus/isolation & purification , Influenza, Human/epidemiology , Aged , Aged, 80 and over , Cross Infection/genetics , Disease Transmission, Infectious , Female , Genotype , Hospitals , Humans , Influenza B virus/genetics , Influenza, Human/transmission , Male , Middle Aged , Molecular Epidemiology , Molecular Typing , Multiplex Polymerase Chain Reaction , Nasopharynx/virology , Real-Time Polymerase Chain Reaction , Retrospective Studies , Sequence Analysis, DNA , Young Adult
3.
Eur J Clin Microbiol Infect Dis ; 36(3): 529-536, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27822652

ABSTRACT

A lack of sensitive tests and difficulties obtaining representative samples contribute to the challenge in identifying etiology in pneumonia. Upper respiratory tract swabs can be easily collected and analyzed with real-time PCR (rtPCR). Common pathogens such as S. pneumoniae and H. influenzae can both colonize and infect the respiratory tract, complicating the interpretation of positive results. Oropharyngeal swabs were collected (n = 239) prospectively from adults admitted to hospital with pneumonia. Analysis with rtPCR targeting S. pneumoniae and H. influenzae was performed and results compared with sputum cultures, blood cultures, and urine antigen testing for S. pneumoniae. Different Ct cutoff values were applied to positive tests to discern colonization from infection. Comparing rtPCR with conventional testing for S. pneumoniae in patients with all tests available (n = 57) resulted in: sensitivity 87 %, specificity 79 %, PPV 59 % and NPV 94 %, and for H. influenzae (n = 67): sensitivity 75 %, specificity 80 %, PPV 45 % and NPV 94 %. When patients with prior antimicrobial exposure were excluded sensitivity improved: 92 % for S. pneumoniae and 80 % for H. influenzae. Receiver operating characteristic curve analysis demonstrated for S. pneumoniae: AUC = 0.65 (95 % CI 0.51-0.80) and for H. influenzae: AUC = 0.86 (95 % CI 0.72-1.00). Analysis of oropharyngeal swabs using rtPCR proved both reasonably sensitive and specific for diagnosing pneumonia caused by S. pneumoniae and H. influenzae. This method may be a useful diagnostic adjunct to other methods and of special value in patients unable to provide representative lower airway samples.


Subject(s)
Haemophilus influenzae/isolation & purification , Molecular Diagnostic Techniques/methods , Oropharynx/microbiology , Pneumonia, Bacterial/diagnosis , Real-Time Polymerase Chain Reaction/methods , Streptococcus pneumoniae/isolation & purification , Adult , Aged , Female , Haemophilus influenzae/genetics , Humans , Male , Middle Aged , Pneumonia, Bacterial/microbiology , Predictive Value of Tests , Prospective Studies , ROC Curve , Sensitivity and Specificity , Streptococcus pneumoniae/genetics
4.
Transplant Proc ; 47(6): 1972-6, 2015.
Article in English | MEDLINE | ID: mdl-26293083

ABSTRACT

BACKGROUND: Hepatitis E virus (HEV) is an important cause of acute and chronic hepatitis in solid organ transplant recipients, especially liver transplant recipients. However, less is known of the incidence and prevalence of HEV in lung transplant recipients. METHODS: In a prospective study, 62 patients were observed during the first year after lung transplantation. Sera were analyzed for anti-HEV immunoglobulin G (IgG) and IgM at 12 months after transplantation. Samples positive for anti-HEV were also analyzed for HEV RNA by polymerase chain reaction. Pretransplantation samples were analyzed for patients with detectable anti-HEV 1 year after transplantation. RESULTS: Eight patients (13%) had anti-HEV IgG at the 12-month follow-up sample. HEV RNA could not be detected in any of these samples. One of these patients seroconverted during the follow-up without developing acute or chronic hepatitis. CONCLUSIONS: Our results show that the prevalence of HEV antibodies among Swedish lung transplant recipients is similar when compared to the general population. It also suggests that the risk for HEV antibody seroconversion during first year is limited.


Subject(s)
Hepatitis Antibodies/immunology , Hepatitis E virus/immunology , Hepatitis E/epidemiology , Lung Transplantation , Transplant Recipients , Adolescent , Adult , Aged , Female , Hepatitis E/immunology , Humans , Immunoglobulin G/blood , Incidence , Male , Middle Aged , Prospective Studies , Sweden/epidemiology , Young Adult
5.
Eur J Clin Microbiol Infect Dis ; 32(7): 947-54, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23435753

ABSTRACT

Human rhinovirus (HRV) is a highly prevalent pathogen and a major cause of acute respiratory tract infection (ARTI). HRV express less seasonality than other viral ARTIs, which typically appear as seasonal epidemics lasting for 1-2 months. The aim of this study was to investigate the seasonal patterns of HRV types over four consecutive years in one geographic region. HRV identified in respiratory samples from 114 patients over a four-year period were analysed by VP4/VP2 sequencing. HRV-A was found in 64, HRV-B in 11 and HRV-C in 37 cases. Overall, 33 different HRV-A types, nine B types and 21 C types were found. As many as 21 of the HRV types appeared during several seasons, with a maximum time-span of four years. Some types appeared during successive seasons and, in some cases, phylogenetic analysis indicated extended periods of circulation locally. Most of the strains were closely related to HRV identified in other parts of the world during the same time period. HRV strains that circulate locally represent many types and seem to reflect that HRV infections are highly globalised. The existence of simultaneous or successive epidemics with different HRV types in combination with the ability of each type to remain in the local population over extended periods of time may contribute to explaining the high rate of HRV infections.


Subject(s)
Picornaviridae Infections/epidemiology , Picornaviridae Infections/virology , Rhinovirus/classification , Rhinovirus/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Cluster Analysis , Female , Genotype , Humans , Infant , Infant, Newborn , Male , Middle Aged , Molecular Epidemiology , Molecular Sequence Data , Phylogeny , Rhinovirus/isolation & purification , Sequence Analysis, DNA , Sequence Homology , Sweden/epidemiology , Viral Structural Proteins/genetics , Young Adult
6.
J Hosp Infect ; 79(1): 27-31, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21764172

ABSTRACT

Norovirus has been associated with excess deaths. A retrospective study of mortality following norovirus enteritis (NVE) was undertaken. All hospitalized adult patients with a stool sample positive for norovirus genogroup II on polymerase chain reaction, treated at Sahlgrenska University Hospital, Gothenburg, Sweden between August 2008 and June 2009, were included as cases (N = 598, aged 18-101 years). Matched controls without enteritis (N = 1196) were selected for comparison. Medical records were reviewed and deaths up to 90 days following positive sampling were noted, as well as comorbidities and length of hospital stay. Thirty- and 90-day survival rates were calculated. Total 30-day mortality was 7.6% and no deaths were recorded in cases aged 18-59 years. Thirty-day mortality was higher in cases with underlying medical conditions compared with those without these comorbidities (age 60-101 years: 89.5% vs 94.7% alive at Day 30, respectively; P < 0.05). In cases aged > 80 years, mortality was higher in those with community-onset NVE (N = 64) compared with hospital-onset NVE (N = 305) (81.2% vs 90.2% alive at Day 30, respectively; P < 0.05), and compared with controls (N = 128) (81.2% vs 91.4% alive at Day 30, respectively; P < 0.05). Median length of hospital stay was 20 [interquartile range (IQR) 12-29] days for cases with hospital-onset NVE, and seven (IQR 2-13) days for controls (P < 0.001). In conclusion, community-onset NVE requiring hospitalization was associated with higher mortality compared with hospital-onset NVE and matched controls in hospitalized elderly patients.


Subject(s)
Caliciviridae Infections/mortality , Community-Acquired Infections/mortality , Enteritis/mortality , Norovirus/isolation & purification , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Case-Control Studies , Feces/virology , Female , Humans , Male , Middle Aged , Retrospective Studies , Sweden/epidemiology , Time Factors , Young Adult
7.
J Neurovirol ; 7(6): 542-7, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11704886

ABSTRACT

The objective of this study was to assess the frequency of blood-brain barrier (BBB) impairment, as measured by the albumin ratio, in neuro-asymptomatic HIV-1-infected individuals without antiretroviral treatment and the correlation between BBB disruption and intrathecal immune activation and HIV-1 RNA levels. Serum and cerebrospinal fluid (CSF) albumin, neopterin, and HIV-1 RNA levels were analysed in 110 neuro-asymptomatic HIV-1-infected individuals at different stages of disease; 63 classified as CDC A, 25 as CDC B, and 22 as CDC C. Increased BBB permeability was found in 17 of 110 (15%) of HIV-1-infected individuals. This proportion was sustained throughout the CDC stages. The albumin ratio was correlated with the CSF neopterin levels (r(s) = 0.36, P < 0.001), the serum neopterin levels (r(s) = 0.37, P < 0.001), and the CSF HIV-1 RNA levels (r(s) = 0.26, P < 0.01), but not with the plasma HIV-1 RNA levels. The correlations between the albumin ratio and the CSF and serum neopterin concentrations and the CSF HIV-1 RNA levels indicate that immune activation and, possibly, intrathecal HIV-1 virus replication are important factors associated with increased BBB permeability in HIV-1 infection.


Subject(s)
Blood-Brain Barrier , HIV Infections/cerebrospinal fluid , HIV Infections/physiopathology , HIV-1/genetics , Neopterin/cerebrospinal fluid , Adolescent , Adult , Aged , Anti-HIV Agents/therapeutic use , Female , HIV Infections/drug therapy , Humans , Male , Middle Aged , Neopterin/blood , RNA, Viral/blood , RNA, Viral/cerebrospinal fluid , Serum Albumin/cerebrospinal fluid
8.
J Med Virol ; 62(1): 9-13, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10935982

ABSTRACT

HIV-1 can be isolated from the vast majority of blood samples taken from HIV-1-seropositive patients not treated with antiretroviral drugs. Isolation rates from cerebrospinal fluid (CSF) samples are considerably lower, ranging between 20-70%. The objective of this study was to determine the cutoff levels for HIV-1 RNA that would yield a positive predictive value > or =90% for positive virus isolation from CSF and blood. Quantitative HIV-1 RNA PCR (Amplicor HIV monitor, version 1.0, Roche Diagnostic Systems) and virus isolation were used to examine 303 CSF samples and 278 paired blood samples from 157 HIV-1-seropositive patients. Patients on antiretroviral treatment provided 140 of the CSF samples and 131 of the blood samples. CSF samples that were positive by culture numbered 137 of 303 (45%), as compared with 216 of 278 (78%) blood samples. In the case of samples taken from patients with antiretroviral treatment, 28% were positive by culture from CSF and 63% from blood. As expected, mean HIV-1 RNA levels were higher in CSF and blood samples positive by culture than in samples negative by culture. A cutoff level of >5,000 HIV-1 RNA copies/ml was required to yield a positive predictive value for positive virus isolation from CSF samples of > or =90%, whereas the cutoff level for blood samples was just above the detection limit of the assay (>200 HIV-1 copies/ml).


Subject(s)
Acquired Immunodeficiency Syndrome/virology , HIV Seropositivity , HIV-1/isolation & purification , RNA, Viral , Acquired Immunodeficiency Syndrome/diagnosis , Acquired Immunodeficiency Syndrome/immunology , Adolescent , Adult , Aged , CD4 Lymphocyte Count , Female , HIV Seropositivity/blood , HIV Seropositivity/cerebrospinal fluid , Humans , Male , Mass Screening , Middle Aged , Predictive Value of Tests , RNA, Viral/blood , RNA, Viral/cerebrospinal fluid , Sensitivity and Specificity
9.
AIDS Res Hum Retroviruses ; 14(12): 1065-9, 1998 Aug 10.
Article in English | MEDLINE | ID: mdl-9718122

ABSTRACT

Human immunodeficiency virus type 1 (HIV-1) invades the central nervous system (CNS) early in the infectious course. The predominant, productively infected cell type within the CNS is the microglial cell. We have analyzed the cerebrospinal fluid (CSF) levels of the ganglioside GD3, a microglia/macrophage and astrocyte marker, in 22 HIV-1-infected individuals at different stages of the disease, and in 44 age-matched HIV-negative, healthy controls. To distinguish between microglial/macrophage and astroglial involvement, the GD3 levels were compared with CSF levels of the glial fibrillary acidic protein (GFAp), which is expressed exclusively in astrocytes. A significantly higher mean CSF concentration of GD3 was found in HIV-1-infected patients compared to controls (56.7 and 40.1 nmol/L, respectively, p < 0.001). Seven of 22 HIV-1-infected patients had increased CSF levels of GD3 (above mean + 2 SD in controls), all but one of these had normal levels of GFAp, indicating a microglial activation or proliferation as the major source of the increased GD3 levels.


Subject(s)
Gangliosides/cerebrospinal fluid , HIV Infections/cerebrospinal fluid , Microglia/pathology , Adult , Biomarkers/cerebrospinal fluid , Glial Fibrillary Acidic Protein/cerebrospinal fluid , HIV Infections/pathology , Humans , Middle Aged
10.
Biochim Biophys Acta ; 1268(1): 27-34, 1995 Jul 20.
Article in English | MEDLINE | ID: mdl-7626659

ABSTRACT

Fibroblasts degrade about 15% of newly synthesised collagen within the cell before it can be secreted. When the helical structure of collagen is disrupted, about 30% is degraded intracellularly. To determine if collagen degradation occurs in a pre-lysosomal compartment, the passage of type 1 collagen out of the endoplasmic reticulum or Golgi was inhibited by incubating human lung fibroblasts with brefeldin A or monensin. In both cases, the type I collagen retained within the cell was stable over a 20 h period. Disrupting the helical structure of collagen with cis-hydroxyproline, 2,2'-bipyridyl or ethyl 3,4-dihydroxybenzoate did not alter the stability of type I collagen in brefeldin or monensin-treated cells. Incubating permeabilised cells in the presence of GTP gamma S (guanosine 5'-(3-O-thio)triphosphate), which blocks transport out of the endoplasmic reticulum, also resulted in the stable retention of type I collagen. Addition of dithiothreitol to permeabilised cells failed to initiate intracellular degradation. Similar results were obtained with fibronectin. Both normal fibronectin and fibronectin in which canavanine replaced arginine were stable for 20 h in cells treated with brefeldin A or monensin. The degradation of native collagen is sensitive to inhibition by a cell-permeable cysteine proteinase inhibitor (ALLN) but is insensitive to chloroquine (which raises the pH of acidic intracellular compartments), whereas the degradation of abnormal collagen was sensitive to both ALLN and chloroquine. These results argue against the intracellular degradation of collagen or fibronectin in a pre-lysosomal compartment.


Subject(s)
Collagen/metabolism , Fibroblasts/metabolism , Fibronectins/metabolism , Lung/metabolism , Organelles/metabolism , 2,2'-Dipyridyl/pharmacology , Biological Transport/drug effects , Brefeldin A , Canavanine/pharmacology , Cell Line , Cell Membrane Permeability , Chloroquine/pharmacology , Collagen/chemistry , Cyclopentanes/pharmacology , Cysteine Proteinase Inhibitors/pharmacology , Endoplasmic Reticulum/drug effects , Fibroblasts/drug effects , Golgi Apparatus/drug effects , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Humans , Hydroxybenzoates/pharmacology , Lung/cytology , Monensin/pharmacology , Protein Folding , Protein Synthesis Inhibitors/pharmacology
11.
Exp Cell Res ; 212(2): 389-92, 1994 Jun.
Article in English | MEDLINE | ID: mdl-8187834

ABSTRACT

The synthesis of metalloproteinases capable of degrading the basement membrane is an important factor contributing to the involution of the mammary gland after the young are weaned. To investigate the cellular source of mammary gland metalloproteinases, we have studied the synthesis of gelatinases by rat mammary epithelial and myoepithelial cell lines immortalized with a temperature-sensitive T-antigen. At 39.5 degrees C, the temperature at which the cells display increased differentiated characteristics, myoepithelial cells synthesize 40- to 160-fold greater amounts of three gelatinases (M(r)s-72, 92, and 135 kDa) than epithelial cells. The gelatinases are preferentially secreted through the basolateral surface of myoepithelial cells. Growth of cells in the presence of a variety of growth factors and cytokines demonstrates the differential regulation of the synthesis of the 72- and 92-kDa gelatinases. These results suggest that the myoepithelial cell is a major source of mammary gland metalloproteinases.


Subject(s)
Gelatinases/metabolism , Mammary Glands, Animal/enzymology , Animals , Cell Line , Cytokines/pharmacology , Epithelium/enzymology , Extracellular Matrix/metabolism , Growth Substances/pharmacology , Mammary Glands, Animal/cytology , Rats
12.
Int J Biochem ; 25(4): 545-50, 1993 Apr.
Article in English | MEDLINE | ID: mdl-8467955

ABSTRACT

1. The degradation of the bone matrix proteins osteocalcin, osteonectin and alpha 2HS-glycoprotein by human cathepsins B and L and human osteoclastoma cathepsins has been investigated. 2. Intermediate degradation products (M(r) > 12 kDa) were not observed during the digestion of alpha 2HS-glycoprotein and osteonectin by cathepsins B and L although they were observed with some of the osteoclastoma cathepsins. Most of the osteoclastoma cathepsins were capable of degrading these two proteins to small peptides at comparable rates. 3. Each cathepsin produced a different pattern of osteocalcin degradation products. 4. The extensive range of non-collagenous proteins in bone matrix may necessitate the production by osteoclasts of cathepsins with different specificities during bone resorption.


Subject(s)
Cathepsins/metabolism , Endopeptidases , Osteocalcin/metabolism , Osteoclasts/enzymology , Osteonectin/metabolism , Blood Proteins/metabolism , Cathepsin B/metabolism , Cathepsin L , Chromatography, High Pressure Liquid , Cysteine Endopeptidases , Giant Cell Tumors/enzymology , Humans , Kinetics , Peptide Fragments/metabolism , Tumor Cells, Cultured , alpha-2-HS-Glycoprotein
SELECTION OF CITATIONS
SEARCH DETAIL
...